The Golden Triangle and the gaps: Rethinking UK biotech

In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll hear from Hakan Goker, managing director at M Ventures and Maina Bhaman, partner at Sofinnova Partners. We explore the UK biotech ecosystem : from the Golden Triangle’s evolving role to the challenges of scaling companies, unlocking pension capital and staying globally competitive. Host Jennifer C. Smith-Parker, Director of Insights, BioSpace Guests Hakan Goker, Managing Director, M VenturesMaina Bhaman, Partner, Sofinnova Partners Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.